Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Revenue (2016 - 2025)

Xtant Medical Holdings has reported Revenue over the past 16 years, most recently at $33.3 million for Q3 2025.

  • Quarterly Revenue rose 19.04% to $33.3 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $133.1 million through Sep 2025, up 16.88% year-over-year, with the annual reading at $117.3 million for FY2024, 28.44% up from the prior year.
  • Revenue was $33.3 million for Q3 2025 at Xtant Medical Holdings, down from $35.4 million in the prior quarter.
  • Over five years, Revenue peaked at $35.4 million in Q2 2025 and troughed at $12.5 million in Q1 2021.
  • The 5-year median for Revenue is $20.2 million (2023), against an average of $22.3 million.
  • Year-over-year, Revenue dropped 15.13% in 2021 and then soared 84.07% in 2023.
  • A 5-year view of Revenue shows it stood at $14.0 million in 2021, then rose by 9.44% to $15.3 million in 2022, then surged by 84.07% to $28.1 million in 2023, then rose by 12.11% to $31.5 million in 2024, then increased by 5.53% to $33.3 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Revenue are $33.3 million (Q3 2025), $35.4 million (Q2 2025), and $32.9 million (Q1 2025).